doi,title,abstract,label_included
,,"involved transitioning from a TNFÎ± inhibitor (including etanercept, infliximab, and adalimumab) originator to a biosimilar
the number of patients who retransitioned was reported or could be calculated
was an original research article published in a peer-reviewed journal
included baseline characteristics of the patients who transitioned
was written in English
the full-text version of the article could be obtained.
original research articles",0
,,"Congress abstracts, reviews, editorials, and other opinion articles",1
